EXPLAINER: Final steps in US review of COVID-19 vaccine
Pfizer's COVID-19 vaccine is entering the final phase of review before the U.S. government decides whether to allow millions to get the shots.
Dec 8, 2020
0
2
Pfizer's COVID-19 vaccine is entering the final phase of review before the U.S. government decides whether to allow millions to get the shots.
Dec 8, 2020
0
2
Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for ...
Nov 18, 2020
0
15
A second experimental COVID-19 vaccine—this one from Moderna Inc.—yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.
Nov 16, 2020
0
17
The United States on Tuesday registered a record 200,000 new COVID-19 cases in one day, highlighting the desperate need for a vaccine after results from one medical trial fuelled optimism around the world.
Nov 10, 2020
0
0
A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama at Birmingham this spring and summer shows potent preclinical immune responses—including several that distinguish it ...
Oct 13, 2020
0
5
A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial—highlighting the potential of a new class of drugs known as ATR inhibitors.
Sep 29, 2020
0
95
A drug candidate developed by Salk researchers, and previously shown to slow aging in brain cells, successfully reversed memory loss in a mouse model of inherited Alzheimer's disease. The new research, published online in ...
Aug 4, 2020
0
1698
Artificial intelligence can increase the effectiveness of drug repositioning or repurposing research, according to a study published in Translational Psychiatry. In the study, which was supported by São Paulo Research Foundation—FAPESP, ...
Aug 3, 2020
0
13
A multi-institutional group of researchers led by Harvard Medical School and the Novartis Institutes for BioMedical Research has created an open-source machine learning tool that identifies proteins associated with drug side ...
Jun 18, 2020
0
43
A total of 155 drugs and 79 vaccines are currently being developed worldwide to combat COVID-19. The Austrian Institute for Health Technology Assessment (AIHTA) has compiled these astonishing figures as part of a new product ...
Apr 20, 2020
0
23